{"id":"https://openalex.org/W2002124497","doi":"https://doi.org/10.1177/0091270004269015","title":"Effects of Fluvoxamine on Lansoprazole Pharmacokinetics in Relation to CYP2C19 Genotypes","display_name":"Effects of Fluvoxamine on Lansoprazole Pharmacokinetics in Relation to CYP2C19 Genotypes","publication_year":2004,"publication_date":"2004-10-20","ids":{"openalex":"https://openalex.org/W2002124497","doi":"https://doi.org/10.1177/0091270004269015","mag":"2002124497","pmid":"https://pubmed.ncbi.nlm.nih.gov/15496639"},"language":"en","primary_location":{"id":"doi:10.1177/0091270004269015","doi":"https://doi.org/10.1177/0091270004269015","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0091270004269015","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088581964","display_name":"Norio Yasui\u2010Furukori","orcid":"https://orcid.org/0000-0002-4414-3770","observed_orcids":["https://orcid.org/0000-0002-4414-3770","https://orcid.org/0000-0003-2710-5964"]},"institutions":[{"id":"https://openalex.org/I146516829","display_name":"Hirosaki University","ror":"https://ror.org/02syg0q74","country_code":"JP","type":"education","lineage":["https://openalex.org/I146516829"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Norio Yasui\u2010Furukori","raw_affiliation_strings":["Department of Clinical Pharmacology, Hirosaki University, School of Medicine, Hirosaki 036-8562, Japan","Department of Clinical Pharmacology, Hirosaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Hirosaki University, School of Medicine, Hirosaki 036-8562, Japan","institution_ids":["https://openalex.org/I146516829"]},{"raw_affiliation_string":"Department of Clinical Pharmacology, Hirosaki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022450878","display_name":"Masato Saito","orcid":"https://orcid.org/0000-0002-2567-6272","observed_orcids":["https://orcid.org/0000-0002-2567-6272"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masato Saito","raw_affiliation_strings":["First Department of Internal Medicine, Hirosaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Department of Internal Medicine, Hirosaki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111533877","display_name":"Tsukasa Uno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146516829","display_name":"Hirosaki University","ror":"https://ror.org/02syg0q74","country_code":"JP","type":"education","lineage":["https://openalex.org/I146516829"]},{"id":"https://openalex.org/I4210165489","display_name":"Hirosaki University Hospital","ror":"https://ror.org/05s3b4196","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I146516829","https://openalex.org/I4210165489"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsukasa Uno","raw_affiliation_strings":["Department of Pharmacy, Hirosaki University Hospital, Japan","Hirosaki University School of Medicine, Hirosaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Hirosaki University Hospital, Japan","institution_ids":["https://openalex.org/I146516829","https://openalex.org/I4210165489"]},{"raw_affiliation_string":"Hirosaki University School of Medicine, Hirosaki, Japan","institution_ids":["https://openalex.org/I146516829"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108765788","display_name":"Takenori Takahata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takenori Takahata","raw_affiliation_strings":["Department of Clinical Pharmacology, Hirosaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Hirosaki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110331014","display_name":"Kazunobu Sugawara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146516829","display_name":"Hirosaki University","ror":"https://ror.org/02syg0q74","country_code":"JP","type":"education","lineage":["https://openalex.org/I146516829"]},{"id":"https://openalex.org/I4210165489","display_name":"Hirosaki University Hospital","ror":"https://ror.org/05s3b4196","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I146516829","https://openalex.org/I4210165489"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazunobu Sugawara","raw_affiliation_strings":["Department of Pharmacy, Hirosaki University Hospital, Japan","Hirosaki University School of Medicine, Hirosaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Hirosaki University Hospital, Japan","institution_ids":["https://openalex.org/I146516829","https://openalex.org/I4210165489"]},{"raw_affiliation_string":"Hirosaki University School of Medicine, Hirosaki, Japan","institution_ids":["https://openalex.org/I146516829"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112583735","display_name":"Tomonori Tateishi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomonori Tateishi","raw_affiliation_strings":["Department of Clinical Pharmacology, Hirosaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Hirosaki, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5088581964"],"corresponding_institution_ids":["https://openalex.org/I146516829"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":1.5919,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.80191154,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"44","issue":"11","first_page":"1223","last_page":"1229"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lansoprazole","display_name":"lansoprazole","score":0.9649999737739563},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":1.0},{"id":"https://openalex.org/keywords/cyp2c19-polymorphism","display_name":"CYP2C19 polymorphism","score":0.8759999871253967},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.6899999976158142},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8109999895095825},{"id":"https://openalex.org/keywords/extensive-metabolizers","display_name":"extensive metabolizers","score":0.6570000052452087},{"id":"https://openalex.org/keywords/poor-metabolizers","display_name":"poor metabolizers","score":0.996999979019165},{"id":"https://openalex.org/keywords/proton-pump-inhibitors","display_name":"proton pump inhibitors","score":0.6439999938011169},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.8149999976158142}],"concepts":[{"id":"https://openalex.org/C2778715759","wikidata":"https://www.wikidata.org/wiki/Q254296","display_name":"Lansoprazole","level":3,"score":0.9872115850448608},{"id":"https://openalex.org/C140840227","wikidata":"https://www.wikidata.org/wiki/Q3737532","display_name":"CYP2C19","level":4,"score":0.8608337640762329},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7801104784011841},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6874175071716309},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.6213098168373108},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5639132261276245},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4827944040298462},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.45387545228004456},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.4247302711009979},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.42302200198173523},{"id":"https://openalex.org/C2777498785","wikidata":"https://www.wikidata.org/wiki/Q422210","display_name":"Omeprazole","level":2,"score":0.3586912751197815},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.348794162273407},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32088136672973633},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.15888270735740662},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.11708119511604309},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.09405720233917236},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000897","descriptor_name":"Anti-Ulcer Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000897","descriptor_name":"Anti-Ulcer Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009853","descriptor_name":"Omeprazole","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009853","descriptor_name":"Omeprazole","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009853","descriptor_name":"Omeprazole","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053799","descriptor_name":"2-Pyridinylmethylsulfinylbenzimidazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054328","descriptor_name":"Proton Pump Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064747","descriptor_name":"Lansoprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/0091270004269015","doi":"https://doi.org/10.1177/0091270004269015","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0091270004269015","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:15496639","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15496639","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1598477089","https://openalex.org/W1905141048","https://openalex.org/W1912895873","https://openalex.org/W1915630750","https://openalex.org/W1964372552","https://openalex.org/W1965447606","https://openalex.org/W1982030762","https://openalex.org/W1985137752","https://openalex.org/W1989584074","https://openalex.org/W1991626196","https://openalex.org/W1992568187","https://openalex.org/W1997586764","https://openalex.org/W2001211486","https://openalex.org/W2002929828","https://openalex.org/W2020651065","https://openalex.org/W2023061643","https://openalex.org/W2023580320","https://openalex.org/W2025836248","https://openalex.org/W2041830516","https://openalex.org/W2045221999","https://openalex.org/W2048808087","https://openalex.org/W2050548785","https://openalex.org/W2075200277","https://openalex.org/W2077642428","https://openalex.org/W2083976782","https://openalex.org/W2085571604","https://openalex.org/W2090977130","https://openalex.org/W2092773999","https://openalex.org/W2093481286","https://openalex.org/W2094722170","https://openalex.org/W2107736762","https://openalex.org/W2130741060","https://openalex.org/W2134817114","https://openalex.org/W2148166921","https://openalex.org/W2156270847","https://openalex.org/W2288991238"],"related_works":["https://openalex.org/W2038889830","https://openalex.org/W1984552762","https://openalex.org/W2004429946","https://openalex.org/W1985137752","https://openalex.org/W1969869235","https://openalex.org/W2033547529","https://openalex.org/W2383204516","https://openalex.org/W2094912801","https://openalex.org/W2099007699","https://openalex.org/W1986328153"],"abstract_inverted_index":{"Lansoprazole":[0],"is":[1,199],"a":[2,66,70,108,166],"substrate":[3],"of":[4,10,19,23,28,57,75,85,125,134,177],"CYP2C19":[5,31,128,180,198],"and":[6,46,87,91,144,194],"CYP3A4.":[7],"The":[8,182],"aim":[9],"this":[11],"study":[12,184],"was":[13,107,160,165],"to":[14,97,122],"compare":[15],"the":[16,26,101,112,115,170,175],"inhibitory":[17],"effects":[18],"fluvoxamine,":[20],"an":[21],"inhibitor":[22],"CYP2C19,":[24],"on":[25,77],"metabolism":[27,204],"lansoprazole":[29,76,86,92,126,135,178,193,203],"between":[30,127,179,192],"genotypes.":[32,129,181],"Eighteen":[33],"volunteers--of":[34],"whom":[35],"6":[36,42,47,79],"were":[37,43,48,94],"homozygous":[38,142],"extensive":[39],"metabolizers":[40,50],"(EMs),":[41],"heterozygous":[44,151],"EMs,":[45,152],"poor":[49],"(PMs)":[51],"for":[52],"CYP2C19--received":[53],"three":[54],"6-day":[55],"courses":[56],"either":[58],"daily":[59],"50":[60],"mg":[61],"fluvoxamine":[62,195],"or":[63],"placebo":[64,104],"in":[65,80,111,141,150,156,162,169,174,196,202,205],"randomized":[67],"fashion":[68],"with":[69],"single":[71],"oral":[72],"60-mg":[73],"dose":[74],"day":[78],"all":[81],"cases.":[82],"Plasma":[83],"concentrations":[84],"its":[88],"metabolites,":[89],"5-hydroxylansoprazole":[90],"sulfone,":[93],"monitored":[95],"up":[96],"24":[98],"hours":[99],"after":[100],"dosing.":[102],"During":[103],"administration,":[105],"there":[106,187],"significant":[109,167,189],"difference":[110,155,168],"area":[113],"under":[114],"plasma":[116],"concentration-time":[117],"curve":[118],"from":[119],"time":[120],"0":[121],"infinity":[123],"(AUC(0-infinity))":[124],"Fluvoxamine":[130],"treatment":[131],"increased":[132],"AUC(0-infinity)":[133,176],"by":[136,145],"3.8-fold":[137],"(P":[138,147],"<":[139,148],".01)":[140],"EMs":[143],"2.5-fold":[146],".05)":[149],"whereas":[153],"no":[154],"any":[157],"pharmacokinetic":[158],"parameters":[159],"found":[161],"PMs.":[163],"There":[164],"fluvoxamine-mediated":[171],"percentage":[172],"increase":[173],"present":[183],"indicates":[185],"that":[186],"are":[188],"drug":[190],"interactions":[191],"EMs.":[197,206],"predominantly":[200],"involved":[201]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}